Abstract:Two different mechanisms are considered to be the primary cause of aging. Cumulative DNA damage caused by reactive oxygen species (ROS), the by-products of oxidative phosphorylation, is one of these mechanisms (ROS concept). Constitutive stimulation of mitogen- and nutrient-sensing mTOR/S6 signaling is the second mechanism (TOR concept). The flow- and laser scanning- cytometric methods were developed to measure the level of the constitutive DNA damage/ROS- as well as of mTOR/S6- signaling in individual cells. Specifically, persistent activation of ATM and expression of γH2AX in untreated cells appears to report constitutive DNA damage induced by endogenous ROS. The level of phosphorylation of Ser235/236-ribosomal protein (RP), of Ser2448-mTOR and of Ser65-4EBP1, informs on constitutive signaling along the mTOR/S6 pathway. Potential gero-suppressive agents rapamycin, metformin, 2-deoxyglucose, berberine, resveratrol, vitamin D3 and aspirin, all decreased the level of constitutive DNA damage signaling as seen by the reduced expression of γH2AX in proliferating A549, TK6, WI-38 cells and in mitogenically stimulated human lymphocytes. They all also decreased the level of intracellular ROS and mitochondrial trans-membrane potential ΔΨm, the marker of mitochondrial energizing as well as reduced phosphorylation of mTOR, RP-S6 and 4EBP1. The most effective was rapamycin. Although the primary target of each on these agents may be different the data are consistent with the downstream mechanism in which the decline in mTOR/S6K signaling and translation rate is coupled with a decrease in oxidative phosphorylation, (revealed by ΔΨm) that leads to reduction of ROS and oxidative DNA damage. The decreased rate of translation induced by these agents may slow down cells hypertrophy and alleviate other features of cell aging/senescence. Reduction of oxidative DNA damage may lower predisposition to neoplastic transformation which otherwise may result from errors in repair of DNA sites coding for oncogenes or tumor suppressor genes. The data suggest that combined assessment of constitutive γH2AX expression, mitochondrial activity (ROS, ΔΨm) and mTOR signaling provides an adequate gamut of cell responses to evaluate effectiveness of gero-suppressive agents.

Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing

mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway

Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling

The mTORC1-autophagy pathway is a target for senescent cell elimination

Suppression of replicative senescence by rapamycin in rodent embryonic cells

Replicative senescence is ATM driven, reversible, and accelerated by hyperactivation of ATM at normoxia

mTORC2: A neglected player in aging regulation

Protein Kinase D1 is Essential for Ras-Induced Senescence and Tumor Suppression by Regulating Senescence-Associated Inflammation

Transient Induction of Telomerase Expression Mediates Senescence and Reduces Tumorigenesis in Primary Fibroblasts.

Regulation of CHK1 by Mtor Contributes to the Evasion of DNA Damage Barrier of Cancer Cells

Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

With TOR, Less is More: A Key Role for the Conserved Nutrient-Sensing TOR Pathway in Aging

Titration of RAS alters senescent state and influences tumour initiation

TORC2 signaling pathway guarantees genome stability in the face of DNA strand breaks

The mTOR pathway is necessary for survival of mice with short telomeres

Mtor Inhibition Attenuates Dna Damage And Apoptosis Through Autophagy-Mediated Suppression Of Creb1